FDA Approves Intrarosa (prasterone) for Postmenopausal Women
The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA)...

https://www.drugs.com/newdrugs/fda-approves-intrarosa-prasterone-postmenopausal-women-experiencing-dyspareunia-4455.html
Like
Comment
Share